MARKET

REGMF

REGMF

Remegen
OTCPK
9.81
NaN%
Closed 09:30 06/12 EDT
OPEN
--
PREV CLOSE
9.81
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
15.91
52 WEEK LOW
5.06
MARKET CAP
2.05B
P/E (TTM)
29.95
1D
5D
1M
3M
1Y
5Y
1D
J.P. Morgan Sticks to Their Buy Rating for RemeGen Co. Ltd. Class H (9995)
TipRanks · 2d ago
RemeGen Co. Ltd. Class H (9995) Gets a Buy from UBS
TipRanks · 3d ago
RemeGen Wins Conditional China Nod for Telitacicept in IgA Nephropathy
TipRanks · 5d ago
RemeGen Wins NMPA Approval for New Telitacicept Indication in Sjögren’s Disease
TipRanks · 5d ago
RemeGen boosts cash management with new RMB300 million SPDB wealth product
TipRanks · 06/01 09:13
Morgan Stanley Keeps Their Hold Rating on RemeGen Co. Ltd. Class H (9995)
TipRanks · 05/30 00:41
RemeGen Expands Use of Idle Funds in HTSC Wealth Products
TipRanks · 05/26 08:38
RemeGen Deploys Idle Funds Into HTSC Wealth Products in Discloseable Transaction
TipRanks · 05/20 10:10
More
About REGMF
RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.

Webull offers RemeGen Co Ltd stock information, including OTCPK: REGMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGMF stock methods without spending real money on the virtual paper trading platform.